XEL
53
-2
NKE
42
6
SLG
53
-2
FLR
52
4
DD
55
2
PSA
51
-2
SYK
55
-4
ESS
59
2
BXP
49
-3
ALLE
35
-2
BK
68
-3
IP
54
-2
VMC
51
3
APH
64
3
PPL
44
-3
RF
48
-3
CCL
72
2
WBA
60
-6
DNB
58
-2
RRC
63
8
XEL
53
-2
NKE
42
6
SLG
53
-2
FLR
52
4
DD
55
2
PSA
51
-2
SYK
55
-4
ESS
59
2
BXP
49
-3
ALLE
35
-2
BK
68
-3
IP
54
-2
VMC
51
3
APH
64
3
PPL
44
-3
RF
48
-3
CCL
72
2
WBA
60
-6
DNB
58
-2
RRC
63
8
Financhill
Back

MillerKnoll 10K Form

Sell
50

MLKN
MillerKnoll

Last Price:
24.94
Seasonality Move:
6.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MLKN News And Ratings

See the #1 stock for the next 7 days that we like better than MLKN

MLKN Financial Statistics

Sales & Book Value

Annual Sales: $3.63B
Cash Flow: $-1.5M
Price / Cash Flow: 11.22
Annual Sales: $19.22
Price / Book: 1.29

Profitability

EPS (TTM): 0.87000
Net Income (TTM): $64.4M
Gross Margin: $1.42B
Return on Equity: 4.34%
Return on Assets: 1.57%

MillerKnoll Earnings Forecast

Key MillerKnoll Financial Ratios

  • The Gross Profit Margin over the past 41 years for MLKN is 39.12%.
  • The Selling, General & Administrative Expenses for MLKN have been equal to 30.65% of Gross Profit Margin.
  • The Research & Development expenses have been 2.55% of Revenue.
  • The Interest Expense is 92.59% of Operating Income.
  • The Net Earning history of MLKN is 2.27% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 26 years.

MillerKnoll Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial Services & Supplies
Sector: Industrials
Current Symbol: MLKN
Website: millerknoll.com

Debt

Debt-to-Equity Ratio: 1.03
Current Ratio: 1.59
Quick Ratio: 0.78

Price-to-Earnings

Trailing P/E Ratio: 22.47
Forward P/E Ratio: 10.04

MLKN Technical Analysis vs Fundamental Analysis

Sell
50
MillerKnoll (MLKN) is a Sell

Is MillerKnoll a Buy or a Sell?

  • MillerKnoll stock is rated a Sell
    The current MillerKnoll [MLKN] share price is $24.94. The Score for MLKN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.